1. Home
  2. SLS vs AMPY Comparison

SLS vs AMPY Comparison

Compare SLS & AMPY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLS
  • AMPY
  • Stock Information
  • Founded
  • SLS 2012
  • AMPY 2011
  • Country
  • SLS United States
  • AMPY United States
  • Employees
  • SLS N/A
  • AMPY N/A
  • Industry
  • SLS Biotechnology: Pharmaceutical Preparations
  • AMPY Oil & Gas Production
  • Sector
  • SLS Health Care
  • AMPY Energy
  • Exchange
  • SLS Nasdaq
  • AMPY Nasdaq
  • Market Cap
  • SLS 165.6M
  • AMPY 162.3M
  • IPO Year
  • SLS N/A
  • AMPY 2011
  • Fundamental
  • Price
  • SLS $1.91
  • AMPY $4.12
  • Analyst Decision
  • SLS Strong Buy
  • AMPY Strong Buy
  • Analyst Count
  • SLS 1
  • AMPY 1
  • Target Price
  • SLS $7.00
  • AMPY $11.00
  • AVG Volume (30 Days)
  • SLS 1.8M
  • AMPY 668.0K
  • Earning Date
  • SLS 08-12-2025
  • AMPY 08-06-2025
  • Dividend Yield
  • SLS N/A
  • AMPY N/A
  • EPS Growth
  • SLS N/A
  • AMPY N/A
  • EPS
  • SLS N/A
  • AMPY 0.38
  • Revenue
  • SLS N/A
  • AMPY $279,289,100.00
  • Revenue This Year
  • SLS N/A
  • AMPY $1.19
  • Revenue Next Year
  • SLS N/A
  • AMPY N/A
  • P/E Ratio
  • SLS N/A
  • AMPY $10.55
  • Revenue Growth
  • SLS N/A
  • AMPY N/A
  • 52 Week Low
  • SLS $0.77
  • AMPY $2.27
  • 52 Week High
  • SLS $2.27
  • AMPY $7.35
  • Technical
  • Relative Strength Index (RSI)
  • SLS 60.77
  • AMPY 61.04
  • Support Level
  • SLS $1.50
  • AMPY $3.72
  • Resistance Level
  • SLS $1.77
  • AMPY $4.18
  • Average True Range (ATR)
  • SLS 0.11
  • AMPY 0.23
  • MACD
  • SLS 0.04
  • AMPY 0.02
  • Stochastic Oscillator
  • SLS 97.62
  • AMPY 91.03

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

About AMPY Amplify Energy Corp.

Amplify Energy Corp is an independent oil and natural gas company engaged in the acquisition, development, exploitation, and production of oil and natural gas properties in the United States. The company's oil and natural gas properties are located in large, mature oil and natural gas reservoirs. The company assets consists of producing oil and natural gas properties located in Oklahoma, the Rockies, federal waters offshore Southern California, East Texas/North Louisiana and Eagle Ford.

Share on Social Networks: